Indegene inks pact with Microsoft to scale Gen AI adoption: stock jumps 5%

Shares of Indegene soared up to 4.81 per cent at Rs 597.25 per share on the BSE after the company on Thursday announced its collaboration with Microsoft to help life sciences firms in scaling up generative AI adoption.

Indegene and Microsoft have committed to developing resources in specialised and skilled medical and technology tools to co-innovate generative AI services and workflows across commercial, medical, regulatory, and clinical functions, the company said in an exchange filing.